Search research articles
Contact Us
Filters
Showing results (121-130 of 132) with videos related to
Page
of 14
Sort By:
Acta Neuropathologica
|
August 7, 2012
Selection of novel reference genes for use in the human central nervous system: a BrainNet Europe Study
Pascal F Durrenberger, Francisca S Fernando, Roberta Magliozzi, et al.
Journal of Parkinson'S Disease
|
September 17, 2019
The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's Disease
Diane Stephenson, Derek Hill, Jesse M Cedarbaum, et al.
Journal of Parkinson'S Disease
|
July 16, 2019
The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's Disease
Diane Stephenson, Derek Hill, Jesse M Cedarbaum, et al.
Journal of Participatory Medicine
|
July 13, 2021
Correction: Data Sharing Goals for Nonprofit Funders of Clinical Trials
Timothy Coetzee, Mad Price Ball, Marc Boutin, et al.
Journal of Participatory Medicine
|
March 29, 2021
Data Sharing Goals for Nonprofit Funders of Clinical Trials
Timothy Coetzee, Mad Price Ball, Marc Boutin, et al.
Journal of Parkinson'S Disease
|
April 5, 2024
Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials Initiative
Richard K Wyse, Tom Isaacs, Roger A Barker, et al.
Acta Neuropathologica
|
March 28, 2008
Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium
Jeanne E Bell, Irina Alafuzoff, Safa Al-Sarraj, et al.
Journal of Parkinson'S Disease
|
June 9, 2020
GDNF and Parkinson's Disease: Where Next? A Summary from a Recent Workshop
Roger A Barker, Anders Björklund, Don M Gash, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 18, 2025
Treatment Selection and Prioritization for the EJS ACT-PD MAMS Trial Platform
Cristina Gonzalez-Robles, Dilan Athauda, Thomas R Barber, et al.
NPJ Parkinson'S Disease
|
November 20, 2024
Accelerating Parkinson's Disease drug development with federated learning approaches
Amit Khanna, Jamie Adams, Chrystalina Antoniades, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 132) with videos related to
Sort By:
Page
of 14
Acta Neuropathologica
|
August 7, 2012
Selection of novel reference genes for use in the human central nervous system: a BrainNet Europe Study
Pascal F Durrenberger, Francisca S Fernando, Roberta Magliozzi, et al.
Journal of Parkinson'S Disease
|
September 17, 2019
The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's Disease
Diane Stephenson, Derek Hill, Jesse M Cedarbaum, et al.
Journal of Parkinson'S Disease
|
July 16, 2019
The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's Disease
Diane Stephenson, Derek Hill, Jesse M Cedarbaum, et al.
Journal of Participatory Medicine
|
July 13, 2021
Correction: Data Sharing Goals for Nonprofit Funders of Clinical Trials
Timothy Coetzee, Mad Price Ball, Marc Boutin, et al.
Journal of Participatory Medicine
|
March 29, 2021
Data Sharing Goals for Nonprofit Funders of Clinical Trials
Timothy Coetzee, Mad Price Ball, Marc Boutin, et al.
Journal of Parkinson'S Disease
|
April 5, 2024
Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials Initiative
Richard K Wyse, Tom Isaacs, Roger A Barker, et al.
Acta Neuropathologica
|
March 28, 2008
Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium
Jeanne E Bell, Irina Alafuzoff, Safa Al-Sarraj, et al.
Journal of Parkinson'S Disease
|
June 9, 2020
GDNF and Parkinson's Disease: Where Next? A Summary from a Recent Workshop
Roger A Barker, Anders Björklund, Don M Gash, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 18, 2025
Treatment Selection and Prioritization for the EJS ACT-PD MAMS Trial Platform
Cristina Gonzalez-Robles, Dilan Athauda, Thomas R Barber, et al.
NPJ Parkinson'S Disease
|
November 20, 2024
Accelerating Parkinson's Disease drug development with federated learning approaches
Amit Khanna, Jamie Adams, Chrystalina Antoniades, et al.
Page
of 14